Globally, over 16 million peripheral vascular procedures were performed in 2020. The majority of these procedures were vascular closure device procedures followed by PTA balloon catheter procedures.

This Global Report Series represents iData’s entire collection of country-level reports in the Global Dental X-Ray Imaging market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s base year: United States (2018) Europe (2018) China (2018) Global Dental

Medical imaging is the technique and process by which images of the human body are created for clinical uses. Types of medical imaging include radiography, nuclear medicine, magnetic resonance, endoscopy, thermography, sonography and photography. Other methods that do not produce images are also considered to be a part of medical imaging, as they provide diagnostic data such as electroencephalography, magnetencephalography and electrocardiography. Prior to the use of medical imaging, physiological issues were investigated through surgery, which posed a much higher risk to the patient. This U.S. medical imaging equipment market includes: X-rays, mammography, magnetic resonance imaging (MRI), computed tomography (CT), nuclear medicine, ultrasound imaging systems as well as contrast agents and injectors.

Industry Trends Digital radiography X-rays are the largest segment, due to their increasing prevalence and popularity; many healthcare facilities prefer digital systems for their increased efficiency and image quality. While analog systems will continue to be sold at nominal levels over the forecast period, they will experience a rapid decline, almost disappearing from the market

The U.S. market for X-ray systems includes analog, computed radiography (CR), digital radiography (DR), fluoroscopy and cardiovascular X-ray systems. DR systems will continue to replace CR systems over the forecast period, while analog systems have almost completely disappeared from the market.

In 2009, the U.S. market for X-ray, mammography and contrast agents was valued at over $5 billion. The medical imaging equipment market includes X-rays, mammography as well as contrast agents and injectors. The market declined in 2009 due to the deficit reduction act, which limited reimbursement for some imaging modalities. In addition, the global economic recession of 2008 to 2009 negatively impacted the market; however, the market is expected to recover beginning in 2010.